Thyroid tablets recalled nationwide over potential ‘superpotency’: FDA

descriptions off, selected

captions settings, opens captions settings dialog

Subtitles (en), selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

End of dialog window.

Today's Top Stories - August 25, 2026

Today's Top Stories - August 25, 2026

(NewsNation) — Vitruvias Therapeutics is voluntarily recalling one lot of thyroid tablets because they could potentially be “superpotent,” federal regulators announced this week.

The high potency 30mg tablets could cause hyperthyroidism, or an overactive thyroid, according to the Food and Drug Administration. The affected lot (504950) was distributed nationwide to Vitruvias Therapeutics’........

© The Hill